Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528235) titled 'An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH' on April 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Tang-Du Hospital
Condition:
Intracerebral Hemorrhage
Stroke-Associated Pneumonia (SAP)
Intervention:
Drug: Intravenous Pump-Delivered Propranolol
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: May 1, 2026
Target Sample ...